Gentium (GENT)

Add to Watchlists Create an Alert
8.69 -0.10  -1.14%   NASDAQ May 23, 2:25PM BATS Real time Currency in USD

Gentium R&D Expense Quarterly:

3.635M for Dec. 31, 2012
View Full Chart

Gentium R&D Expense Quarterly Chart

    Gentium Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 4.304M
    Dec. 31, 2012 3.635M
    Sept. 30, 2012 3.585M
    June 30, 2012 3.531M
    March 31, 2012 2.894M
    Dec. 31, 2011 1.546M
    Sept. 30, 2011 2.276M
    June 30, 2011 2.059M
    March 31, 2011 1.729M
    Dec. 31, 2010 1.956M
    Sept. 30, 2010 1.593M
    June 30, 2010 2.482M
    March 31, 2010 1.898M
    Dec. 31, 2009 1.226M
    Sept. 30, 2009 1.239M
    June 30, 2009 0.5099M
       
    March 31, 2009 1.907M
    Dec. 31, 2008 2.398M
    Sept. 30, 2008 3.606M
    June 30, 2008 2.775M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    GENT R&D Expense Quarterly Benchmarks

    Companies
    Acura Pharmaceuticals 2.026M
    Horizon Pharma 4.739M
    Sagent Pharmaceuticals 4.261M

    GENT R&D Expense Quarterly Rankings

    Overall 88th percentile
    932 of 8006
    Sector 60th percentile
    270 of 686 in Healthcare
    Industry 44th percentile
    38 of 68 in Drug Manufacturers - Specialty & Generic

    GENT R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.5099M Jun 2009
    Maximum 4.304M Mar 2013
    Average 2.357M